货号: CL-0059
Price: ¥1600 ¥1600
生长培养基: IMDM[PM150510]+10% FBS[164210]+1% P/S[PB180120]
产品信息
产品名称 | CFPAC-1(人胰腺癌细胞) |
别称 | CFPac-1; CF PAC-1; CF-PAC1; CF-Pac1; CF Pac1; CFPAC1; CFPac1; CFPAC |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:IMDM[PM150510]+10% FBS[164210]+1% P/S[PB180120] 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:3-1:4 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | CFPAC-1细胞是胰腺管腺癌细胞系,建自26岁白人男性囊性纤维变性(CF)的肝转移灶。CFPAC-1细胞表达囊性纤维变性跨膜调节因子(CFTR),CFPAC-1细胞形态为上皮细胞样且顶端微绒毛极化。CFPAC-1细胞表达胰腺管细胞特征性的细胞角蛋白和癌胚抗原,倍增时间为30-32小时。CFPAC-1细胞是亚3倍体的细胞系,36%的细胞的染色体模式数为75。CFPAC-1细胞传代至24代时,可在免疫抑制小鼠中致瘤。 |
年龄(性别) | 26Y Male |
组织来源 | 胰腺管腺癌,肝转移 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 胰腺癌细胞 |
生物安全等级 | BSL-1 |
致瘤性 | Yes, in nude mice (passage 34). |
STR位点信息
STR鉴定图
-
Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma(2023)
作者:Huang Qian, Peng Xingyu, Li Qingqing, Zhu Jinfeng, Xue Ju, Jiang Hua
期刊:Frontiers in Immunology
DOI:10.3389/fimmu.2023.1111494
影响因子:7.3
引用产品: CFPAC-1 细胞, CFPAC-1细胞专用培养基
-
Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy(2023)
作者:Shi Yanlong, Wang Yizhu, Dong Hui, Niu Kaiyi, Zhang Wenning, Feng Kun, Yang Rui, Zhang Yewei
期刊:APOPTOSIS
DOI:10.1007/s10495-023-01868-8
影响因子:7.2
引用产品: HPNE 细胞, CFPAC-1 细胞, SW 1990 细胞, BxPC-3 细胞
-
PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression(2023)
作者:Ma Jia, Zhou Wenyang, Yuan Yifeng, Wang Baosheng, Meng Xiangpeng
期刊:CANCER GENE THERAPY
DOI:10.1038/s41417-023-00609-y
影响因子:6.4
引用产品: CFPAC-1 细胞, IMDM 培养基, Leibovitz's L-15 培养基
-
5′-tRF-19-Q1Q89PJZ Suppresses the Proliferation and Metastasis of Pancreatic Cancer Cells via Regulating Hexokinase 1-Mediated Glycolysis(2023)
作者:Wenpeng Cao, Zhirui Zeng, Shan Lei
期刊:Biomolecules
影响因子:5.5
引用产品: MIA PaCa-2 细胞, PANC-1 细胞, CFPAC-1 细胞, Capan-2 细胞, SW 1990 细胞, BxPC-3 细胞, AsPC-1 细胞, 人胰腺上皮细胞
-
RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines(2023)
作者:Hui Dong, Haidong Zhang, Xinyu Mao, Shiwei Liu, Wenjing Xu, Yewei Zhang
期刊:Cancers
影响因子:5.2
引用产品: HPNE 细胞, CFPAC-1 细胞, BxPC-3 细胞
-
COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bioinformatics and Experimental Validation(2023)
作者:Yao Song, Lei Wang, Kaidong Wang, Yuhua Lu, Pengcheng Zhou
期刊:Cancers
影响因子:5.2
引用产品: PANC-1 细胞, BxPC-3 细胞, CFPAC-1 细胞, PATU8988 细胞, AsPC-1 细胞, MIA PaCa-2 细胞
-
Identifying endoplasmic reticulum stress-related molecular subtypes and prognostic model for predicting the immune landscape and therapy response in pancreatic cancer(2023)
作者:Biao Zhang, Xu Chen, Zhizhou Wang, Fangyue Guo, Xiaonan Zhang, Bingqian Huang, Shurong Ma, Shilin Xia, Dong Shang
期刊:Aging-US
影响因子:5.2
引用产品: CFPAC-1 细胞, PANC-1 细胞
-
GID2 Interacts With CDKN3 and Regulates Pancreatic Cancer Growth and Apoptosis(2023)
作者:Xin Deng, Jia Ma, Wenyang Zhou, Yifeng Yuan, Baosheng Wang, Xiangpeng Meng
期刊:LABORATORY INVESTIGATION
DOI:10.1016/j.labinv.2023.100122
影响因子:5.0
引用产品: CFPAC-1 细胞, IMDM 培养基, Leibovitz's L-15 培养基
-
Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer(2023)
作者:Chen Junliang, Liu Zhihao, Wu Zhiyuan, Li Wenjun, Tan Xiaodong
期刊:Frontiers in Oncology
影响因子:4.7
引用产品: AsPC-1 细胞, CFPAC-1 细胞, PANC-1 细胞, IMDM 培养基, DMEM高糖 培养基, 特级胎牛血清, 青霉素-链霉素溶液 (双抗),100×
-
PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer(2023)
作者:Zhang Biao, Huang Bingqian, Zhang Xiaonan, Li Shuang, Zhu Jingyi, Chen Xu, Song Huiyi, Shang Dong
期刊:Frontiers in Oncology
影响因子:4.7
引用产品: PANC-1 细胞, CFPAC-1 细胞
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图